COVID-19 and Immunodeficiency
Corona viruses a type of virus that causes respiratory disorder such as the common cold to more acute diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Majority of people with immune deficiencies and those on immune-suppressing drugs are immune compromised, putting them at a higher risk of respiratory diseases. The most common symptomatic primary immunodeficiency in adults is common element immunodeficiency. Affected patients do not establish an adequate humoral react to community-acquired viral illnesses, and recent researches have found evidence that these patients are more susceptible to severe SARS-CoV-2 infections. The injection of COVID-19 convalescent plasma could be varying in treatment technique in this case.
- Primary immunodeficiency
- SARS-CoV-2
- COVID-19 convalescent plasma
- Genetic defects
- Covid-19 Alpha variant
- Primary immunodeficiency
- COVID-19 convalescent plasma
- SARS-CoV-2
- Genetic defects
Related Conference of COVID-19 and Immunodeficiency
5th International conference on Vaccines, Vaccination and Immunization
COVID-19 and Immunodeficiency Conference Speakers
Recommended Sessions
- Allergy Medicine and Alternatives
- Anaphylaxis and Asthma
- Clinical Immunology and Allergy
- COVID-19 and Immunodeficiency
- Diagnostic Immunology
- Future of Food Allergy
- Immune Disorders
- Immunotherapy and Transplantation
- Immunotherapy in Cancer treatment
- Infection and Immunity
- Latest Research on Allergy Treatment
- Market and Future of Therapeutics in Immunology
- Molecular and Cellular Mechanisms of Allergic Diseases
- Neonatal and Pediatric Immunology
- Neuro Infection Treatment
- Prevention and Therapy of Allergic Diseases
- Skin Allergy and Ocular Allergy
- Types of Seasonal Allergies
- Vaccines and Immunization
- Veterinary Allergology
Related Journals
Are you interested in
- Cancer Immunology and Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Cell & Plant Biology - IMMUNOLOGY 2024 (Spain)
- Cell Biology - IMMUNOLOGY 2024 (Spain)
- CELL, ANIMAL & PLANT BIOLOGY - IMMUNOLOGY 2024 (Spain)
- Clinical Immunology & Current & Future Research - IMMUNOLOGY 2024 (Spain)
- Immune System - IMMUNOLOGY 2024 (Spain)
- Immuno informatics & Systems immunology - IMMUNOLOGY 2024 (Spain)
- Immuno-Genetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics - IMMUNOLOGY 2024 (Spain)
- Immunohistochemistry - IMMUNOLOGY 2024 (Spain)
- Immunology - IMMUNOLOGY 2024 (Spain)
- Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Nutritional Immunology - IMMUNOLOGY 2024 (Spain)
- OncoImmunology - IMMUNOLOGY 2024 (Spain)
- Pediatric and Neonatal Immunology - IMMUNOLOGY 2024 (Spain)
- Reproductive Immunology - IMMUNOLOGY 2024 (Spain)
- Transplantation and Computational Immunology - IMMUNOLOGY 2024 (Spain)
- Vaccines & Immunization - IMMUNOLOGY 2024 (Spain)
- Virology and infectious diseases - IMMUNOLOGY 2024 (Spain)